Detecting Change in Muscle Parameters, Pain, and Function With NMES for TTA

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 10, 2024

Primary Completion Date

August 30, 2025

Study Completion Date

December 30, 2025

Conditions
Amputation
Interventions
DEVICE

Chattanooga Continuum Device

The Chattanooga Continuum (Enovis, Wilmington, DE) is an FDA-approved, multi-functional, dual-channel electrotherapy device that offers adjunctive rehabilitation therapies, including muscle re-education (NMES), pain control, and stimulation of local blood circulation. The device provides a treatment duration of up to 60 minutes, allowing for cycled or continuous therapy. It offers symmetrical and asymmetrical waveform types, adjustable pulse rates of up to 150 Hz, and pulse width durations of up to 400 μs. The device also features off times, channel ramp times, and on time settings. Additionally, the Continuum is equipped with a data and parameter logger, enabling the monitoring of patient usage. It incorporates an automatic lock function to prevent accidental changes in intensity by preventing unintended pressing of the control buttons. The device operates on two AA rechargeable NiMH batteries, and a battery charger and extra batteries are included with the device.

Trial Locations (1)

16066

RECRUITING

Cranberry Township Building, Pittsburgh

All Listed Sponsors
lead

Sara Peterson-Snyder

INDUSTRY